Iovance Biotherapeutics (IOVA) Treasury Shares (2014 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Treasury Shares of $13.9 million for Q1 2026, up 14.58% year-over-year from $12.2 million in Q1 2025, and up 53.44% quarter-over-quarter from $9.1 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Treasury Shares (2014 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Treasury Shares for 13 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 14.58% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $13.9 million (up 14.58% YoY), while the FY2025 annual figure was $9.1 million, down 4.89% from the prior year.
- Treasury Shares advanced to $13.9 million in Q1 2026 per IOVA's latest filing, from $9.1 million in the prior quarter.
- Across five years, Treasury Shares topped out at $13.9 million in Q1 2026 and bottomed at $2.4 million in Q4 2022.
- Historically, Treasury Shares has averaged $7.4 million across 5 years, with a median of $9.1 million in 2025.
- Annual changes were most pronounced in 2024 — Treasury Shares surged 208.93% — and 2025, when it declined 4.89%.
- Iovance Biotherapeutics' Treasury Shares stood at $2.4 million in 2022, then jumped by 41.74% to $3.5 million in 2023, then soared by 176.43% to $9.5 million in 2024, then retreated by 4.89% to $9.1 million in 2025, then soared by 53.44% to $13.9 million in 2026.
- Business Quant data shows IOVA's Treasury Shares at $13.9 million in Q1 2026, $9.1 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 12.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.71 Mn |
| Jun 30, 2026 | 12.71 Mn |
| Mar 31, 2026 | 13.93 Mn |
| Mar 31, 2026 | 13.93 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 9.88 Mn |
| Sep 30, 2025 | 9.88 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Mar 31, 2025 | 12.16 Mn |
| Mar 31, 2025 | 12.16 Mn |
| Dec 31, 2024 | 9.55 Mn |
| Dec 31, 2024 | 9.55 Mn |
| Sep 30, 2024 | 9.92 Mn |
| Sep 30, 2024 | 9.92 Mn |
| Jun 30, 2024 | 11.84 Mn |
| Jun 30, 2024 | 11.84 Mn |
| Mar 31, 2024 | 12.08 Mn |
| Mar 31, 2024 | 12.08 Mn |